glp-1 agonists for type 2 diabetes The activity of and GIP and Obesity GLP-1 Receptor Agonists for Type
Description
There is no 12-week cutoff
Studies are still being conducted to better understand the impact that GLP-1s like Wegovy (and other GLP-1-based drugs) have on weight loss
Most prescribing guidelines recommend 8 to 12 weeks of treatment, followed by a break
they provide a glimpse into the next frontier of obesity care
J., & Greenway, F
